Jupiter Neurosciences, Inc. (JUNS) stock
JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.70−0.06 (-3.41%)
Close on Nov 16, 2026Market cap $1.31MP/E –Yield –
Jupiter Neurosciences EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Jupiter Neurosciences
Jupiter Neurosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?